This journal examines the clinical course of autoimmune hepatitis (AIH) in Hispanic and African American patients at a South Bronx hospital. The findings contribute to a better understanding of AIH in diverse racial and ethnic groups, emphasizing the need for tailored healthcare strategies.
This journal compares the effectiveness of Heplisav-B and standard hepatitis B vaccines as boosters for healthcare workers with low immunity to hepatitis B, measured by anti-HBs antibody levels. Results show that Heplisav-B offers a significantly higher seropositivity rate (99.4%) compared to the standard vaccine (92.7%).
This journal outlines best practices for engaging communities affected by chronic hepatitis B, emphasizing the importance of involving individuals with lived experiences in public health initiatives to improve diagnosis and treatment outcomes.
This journal evaluates the Oregon HOPE TeleHCV study, a peer-facilitated telemedicine model (Peer TeleHCV) for hepatitis C virus (HCV) treatment among people who use drugs (PWUD) in rural Oregon. The findings highlight high patient satisfaction and key factors that enhanced implementation, demonstrating the model’s potential to reduce barriers and improve treatment access.
This report outlines progress toward eliminating mother-to-child transmission of hepatitis B virus (HBV) in the Americas from 2012 to 2022. It highlights improvements in vaccination coverage, including birth doses, but also notes coverage declines in some countries, which could hinder elimination goals. The report emphasizes the need for maintaining high vaccination rates, expanding hepatitis B testing for pregnant women, and ensuring timely treatment for newborns.
This guideline outlines the importance of Medicaid 1115 waivers and pre-release healthcare coverage in improving access to hepatitis C (HCV) treatment for incarcerated individuals. It discusses how expanding Medicaid coverage can enhance continuity of care, reduce transmission, and support reentry populations.
This fact sheet provides critical guidance for healthcare providers on managing patients with hepatitis C virus (HCV). It outlines key steps for diagnosis, treatment, and referral, emphasizing the importance of early detection and timely intervention. The fact sheet aims to equip healthcare providers with essential tools and resources to improve patient outcomes and prevent the spread of HCV through effective care strategies.
This report outlines the progress made toward the elimination of mother-to-child transmission of hepatitis B virus in the Region of the Americas from 2012 to 2022. It highlights key strategies, achievements, and challenges in achieving the goal of reducing the transmission rates, providing a comprehensive overview of regional efforts to combat this public health issue.
This webpage provides the Vaccine Information Statement (VIS) for the hepatitis B vaccine, detailing the vaccine's purpose, the diseases it prevents, the recommended vaccination schedule, potential side effects, and important information for healthcare providers. It serves as an essential resource for understanding the importance of hepatitis B vaccination.
This report proposes policies for expanding access to hepatitis C (HCV) testing and treatment in United States jails and prisons. The report's policy recommendations draw principally from settlement agreements, judicial opinions, and other filings in those cases, supplemented by current medical guidance and input from public health experts, medical professionals, and advocates.
